☆ 4.5 Article

Efficient synthesis and evaluation of novel 6-arylamino-[1,2,4]triazolo [4,3-a]pyridine derivatives as antiproliferative agents

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Chemistry, Medicinal

Identification of triazolopyridine derivatives as a new class of AhR agonists and evaluation of anti-psoriasis effect in a mouse model

Chenyu Tian et al.

Summary: Triazolopyridine derivatives have been discovered as a new class of AhR agonists that can regulate the immune balance of Th17/22 and Treg cells, thus playing a crucial role in the development and maintenance of the skin barrier. Among them, compound 12a exhibits the most potent activity and promotes skin barrier repair. Topical or oral administration of 12a shows significant alleviation of psoriasis-like skin lesions.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Article Chemistry, Medicinal

Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies

Ying Huang et al.

Summary: PRC2 plays a crucial role in animal development and cell differentiation, and its alteration has been linked to cancer. The compound EED226 has shown potential to inhibit PRC2 activity and reduce tumor growth.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of indole-based [1,2,4] triazolo[4,3-a] pyridine derivatives as novel microtubule polymerization inhibitors

Cheng-Jun Wu et al.

Summary: A series of novel microtubulin polymerization inhibitors based on indole were designed and synthesized, among which compound 12d exhibited the highest antiproliferative activity by inducing cellular apoptosis, cell cycle arrest, and inhibiting tubulin polymerization.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Article Chemistry, Medicinal

The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors

Silvia Fallarini et al.

Summary: Inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) are considered a promising strategy in cancer immunotherapy, and recent studies have revealed additional roles of IDO1 beyond its catalytic activity. A novel class of compounds, originated from a structure-based virtual screening on IDO1 active site, has shown improved potency, metabolic stability, and selectivity after rational and in silico-guided design of analogues.

CHEMMEDCHEM (2021)

添加到收藏夹

Review Chemistry, Medicinal

Current Status of Novel Pyridine Fused Derivatives as Anticancer Agents: An Insight into Future Perspectives and Structure Activity Relationship (SAR)

Ajay Manaithiya et al.

Summary: Cancer, a prevalent heterogeneous disease, calls for more effective drugs. Oxygen and nitrogen-based heterocyclic compounds have shown therapeutic activity, with pyrido fused five-membered heterocyclic rings being highlighted as important anticancer drugs.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Article Chemistry, Medicinal

Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73

Joel W. Beatty et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Article Chemistry, Medicinal

Synthesis, and biological evaluation of 3,6-diaryl-[1,2,4]triazolo[4,3-a] pyridine analogues as new potent tubulin polymerization inhibitors

Fang Yang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Pyridine Based Antitumour Compounds Acting at the Colchicine Site

R. Alvarez et al.

CURRENT MEDICINAL CHEMISTRY (2016)

添加到收藏夹

Review Pathology

Recent advancements of flow cytometry: new applications in hematology and oncology

Janghee Woo et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2014)

添加到收藏夹

Article Chemistry, Medicinal

Novel triazolopyridylbenzamides as potent and selective p38α inhibitors

Josep Aiguade et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

添加到收藏夹

Article Chemistry, Medicinal

Discovery of 3-Cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): A Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor

Jose Maria Cid et al.

JOURNAL OF MEDICINAL CHEMISTRY (2012)

添加到收藏夹

Article Chemistry, Organic

A practical Buchwald-Hartwig amination of 2-bromopyridines with volatile amines

Jie Jack Li et al.

JOURNAL OF ORGANIC CHEMISTRY (2007)

添加到收藏夹

Article Chemistry, Medicinal

Synthesis and SAR of [1,2,4]Triazolo[1,5-a]pyrimidines, a class of anticancer agents with a unique mechanism of tubulin inhibition

Nan Zhang et al.

JOURNAL OF MEDICINAL CHEMISTRY (2007)

添加到收藏夹

Article Chemistry, Medicinal

Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties

D Kim et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)

添加到收藏夹

Article Chemistry, Medicinal

Hypervalent iodine mediated synthesis of 1-aryl/hetryl-1,2,4-triazolo[4,3-a] pyridines and 1-aryl/hetryl 5-methyl-1,2,4-triazolo[4,3-a]quinolines as antibacterial agents

AK Sadana et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.